Arecor Therapeutics plc
(“Arecor” or “the Company”)
AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES
News
Lehane Consulting Ltd are celebrating our 1 year anniversary! We launched our services in 2023 and have enjoyed a fantastic first year of building our network, sharing our skills and welcoming new customers. To mark our birthday in style, we would like to offer One Nucleus members the opportunity for a 20 minute introductory call - to meet, engage and explore the potential of new projects in 2024.
Drop an email to Lucy@Lehaneconsulting.co.uk quoting #YearOneNucleus
We are delighted to share the results from Aon's 2023 Global Risk Management Survey (GRMS).
The GRMS collects and analyses business leaders' assessment of risk and risk management. The 2023 report is the ninth edition of the survey and the results from both Global and UK respondents reflect the increasingly interconnected nature of risk, with traditional business risks and people risks converging to create significant challenges for organisations.
|
Aon – Life Science Sector Specific Employee Benefits Survey:
Participating in this targeted survey can give you unique data insight to help:
The Cambridge Wide Open Day event on Wednesday 12th June is a unique opportunity for all to find out firsthand about the game-changing scientific advancements and technological innovations happening right here in our city, the UK’s science and tech capital.
The cream of Cambridge science and technology is opening its doors to participate in this year’s Be Curious event across the four main science clusters located in:
Produced using dry-spun 50 µm Collagen Type I fibers, AMSBIO has introduced the innovative CollaFibR™ additive proven to increase the shape fidelity and biological relevance of bioprinted constructs in hydrogels and bioinks.
In the field of personalized tissue engineering, 3D bioprinting shows immense promise, but the challenge lies in achieving both mechanical durability and biological relevance in the printed constructs.
SALT LAKE CITY, US and OXFORD, UK – 13 May 2024 – The leading US multi-specialty healthcare center, Metrodora Institute, and pioneering precision medicine company, PrecisionLife, announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders. The partners have developed genotypic diagnostic tests that are now being evaluated for their ability to provide clinicians with an accurate view of a patient’s risk of a specific disease.
Arecor Therapeutics plc
(“Arecor” or the “Company”)
ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY
- Medtronic to fund Arecor’s development of Arestat™ enabled novel, high concentration, thermostable insulin, specifically tailored for use in combination with a next-generation implantable pump
DISCOVERY PARK BUSINESS A4P RECEIVES THE KING’S AWARD FOR ENTERPRISE IN INTERNATIONAL TRADE
The most prestigious business award in the United Kingdom.